Search
Erzotabart
go.drugbank.com/drugs/DB19063InvestigationalErzotabart is under investigation in clinical trial NCT04824794 (GEN3014 Safety Trial in Relapsed or Refractory Hematologic Malignancies).
Amitraz
go.drugbank.com/drugs/DB11373ExperimentalVet approvedAmitraz presents a lower effect in mammals and thus, it is widely used in the treatment of mite- or tick-infestation of dogs.
Categories: Compounds used in a research, industrial, or household setting3-Methylfentanyl
go.drugbank.com/drugs/DB01571ExperimentalIllicit3-Methylfentanyl is an opioid analgesic and is an analog of the potent opioid, fentanyl. 3-Methylfentanyl is one of the most powerful opioid drugs sold illegally and is estimated to be between 400-6000 times more potent than morphine in ...
Digoxin
go.drugbank.com/drugs/DB00390ApprovedInvestigationalDigoxin is one of the oldest cardiovascular medications used today. It is a common agent used to manage atrial fibrillation and the symptoms of heart failure. Digoxin is classified as a cardiac glycoside and was initially approved by the...
Categories: Compounds used in a research, industrial, or household settingProducts: DIGOXINA POR 0.25MG CAPSULAS BLANDASNCX 1022
go.drugbank.com/drugs/DB05410ExperimentalNCX is an NO-releasing derivative of hydrocortisone.
4-Methoxyamphetamine
go.drugbank.com/drugs/DB01472ExperimentalIllicitCategories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesPhenibut
go.drugbank.com/drugs/DB13455ExperimentalCategories: Psychostimulants, Agents Used for ADHD and NootropicsImidafenacin
go.drugbank.com/drugs/DB09262InvestigationalImidafenacin is an antispasmodic agent with anticholinergic effects. It antagonizes muscarinic receptors in the bladder to reduce the frequency of urination in the treatment of overactive bladder. It is marketed in Japan under the traden...
Categories: Drugs for Urinary Frequency and IncontinenceCilostazol
go.drugbank.com/drugs/DB01166ApprovedInvestigationalCilostazol is a quinolinone derivative and antiplatelet agent with vasodilating properties that has been used in the symptomatic treatment of intermittent claudication in patients with peripheral ischaemia. It is marketed under the brand...
Categories: Compounds used in a research, industrial, or household settingAZD-5991
go.drugbank.com/drugs/DB14792InvestigationalAZD-5991 is under investigation in clinical trial NCT03218683 (Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.).